BACKGROUND: Obesity and asthma have increased in westernised countries. Maternal obesity may increase childhood asthma risk. If this relation is causal, it may be mediated through factors associated with maternal adiposity, such as fetal development, pregnancy complications or infant adiposity. We investigated the relationships of maternal body mass index (BMI) and fat mass with childhood wheeze, and examined the influences of infant weight gain and childhood obesity. METHODS: Maternal prepregnancy BMI and estimated fat mass (from skinfold thicknesses) were related to asthma, wheeze and atopy in 940 children. Transient or persistent/late wheeze was classified using questionnaire data collected at ages 6, 12, 24 and 36 months and 6 years. At 6 years, skin-prick testing was conducted and exhaled nitric oxide and spirometry measured. Infant adiposity gain was calculated from skinfold thickness at birth and 6 months. RESULTS: Greater maternal BMI and fat mass were associated with increased childhood wheeze (relative risk (RR) 1.08 per 5 kg/m(2), p=0.006; RR 1.09 per 10 kg, p=0.003); these reflected associations with transient wheeze (RR 1.11, p=0.003; RR 1.13, p=0.002, respectively), but not with persistent wheeze or asthma. Infant adiposity gain was associated with persistent wheeze, but not significantly. Adjusting for infant adiposity gain or BMI at 3 or 6 years did not reduce the association between maternal adiposity and transient wheeze. Maternal adiposity was not associated with offspring atopy, exhaled nitric oxide, or spirometry. DISCUSSION: Greater maternal adiposity is associated with transient wheeze but not asthma or atopy, suggesting effects upon airway structure/function but not allergic predisposition.
BACKGROUND: Obesity and asthma have increased in westernised countries. Maternal obesity may increase childhood asthma risk. If this relation is causal, it may be mediated through factors associated with maternal adiposity, such as fetal development, pregnancy complications or infant adiposity. We investigated the relationships of maternal body mass index (BMI) and fat mass with childhood wheeze, and examined the influences of infant weight gain and childhood obesity. METHODS: Maternal prepregnancy BMI and estimated fat mass (from skinfold thicknesses) were related to asthma, wheeze and atopy in 940 children. Transient or persistent/late wheeze was classified using questionnaire data collected at ages 6, 12, 24 and 36 months and 6 years. At 6 years, skin-prick testing was conducted and exhaled nitric oxide and spirometry measured. Infant adiposity gain was calculated from skinfold thickness at birth and 6 months. RESULTS: Greater maternal BMI and fat mass were associated with increased childhood wheeze (relative risk (RR) 1.08 per 5 kg/m(2), p=0.006; RR 1.09 per 10 kg, p=0.003); these reflected associations with transient wheeze (RR 1.11, p=0.003; RR 1.13, p=0.002, respectively), but not with persistent wheeze or asthma. Infant adiposity gain was associated with persistent wheeze, but not significantly. Adjusting for infant adiposity gain or BMI at 3 or 6 years did not reduce the association between maternal adiposity and transient wheeze. Maternal adiposity was not associated with offspring atopy, exhaled nitric oxide, or spirometry. DISCUSSION: Greater maternal adiposity is associated with transient wheeze but not asthma or atopy, suggesting effects upon airway structure/function but not allergic predisposition.
Authors: Israel Hendler; Sean C Blackwell; Shobha H Mehta; Janice E Whitty; Evelyne Russell; Yoram Sorokin; David B Cotton Journal: Am J Obstet Gynecol Date: 2005-09 Impact factor: 8.661
Authors: Sarah R Crozier; Hazel M Inskip; Keith M Godfrey; Cyrus Cooper; Nicolas C Harvey; Zoë A Cole; Siân M Robinson Journal: Am J Clin Nutr Date: 2010-04-07 Impact factor: 7.045
Authors: J A Castro-Rodríguez; C J Holberg; W J Morgan; A L Wright; F D Martinez Journal: Am J Respir Crit Care Med Date: 2001-05 Impact factor: 21.405
Authors: M I Asher; U Keil; H R Anderson; R Beasley; J Crane; F Martinez; E A Mitchell; N Pearce; B Sibbald; A W Stewart Journal: Eur Respir J Date: 1995-03 Impact factor: 16.671
Authors: M I Gunnbjörnsdóttir; E Omenaas; T Gíslason; E Norrman; A C Olin; R Jõgi; E J Jensen; E Lindberg; E Björnsson; K Franklin; C Janson; A Gulsvik; B Laerum; C Svanes; K Torén; A Tunsäter; L Lillienberg; D Gíslason; T Blöndal; U S Björnsdottir; K B Jörundsdóttir; R Talvik; B Forsberg; K Franklin; B Lundbäck; M Söderberg; M C Ledin; G Boman; D Norbäck; G Wieslander; U Spetz-Nyström; K Stenudd Cashelunge; E Rydén Journal: Eur Respir J Date: 2004-07 Impact factor: 16.671
Authors: Katharine C Pike; Sarah R Crozier; Jane S A Lucas; Hazel M Inskip; Sian Robinson; Graham Roberts; Keith M Godfrey Journal: Thorax Date: 2010-10-18 Impact factor: 9.139
Authors: Maria C Magnus; Siri E Håberg; Øystein Karlstad; Per Nafstad; Stephanie J London; Wenche Nystad Journal: Thorax Date: 2015-01-08 Impact factor: 9.139
Authors: Kelvin D MacDonald; Kimberly K Vesco; Kristine L Funk; Jerena Donovan; Thuan Nguyen; Zunqiu Chen; Jodi A Lapidus; Victor J Stevens; Cindy T McEvoy Journal: Pediatr Pulmonol Date: 2016-01-21
Authors: Ashley Rajappan; Anna Pearce; Hazel M Inskip; Janis Baird; Sarah R Crozier; Cyrus Cooper; Keith M Godfrey; Graham Roberts; Jane S A Lucas; Katharine C Pike Journal: Pediatr Pulmonol Date: 2017-08-16
Authors: Rajesh Kumar; Ryan P Ferrie; Lauren C Balmert; Matthew Kienzl; Sheryl L Rifas-Shiman; Diane R Gold; Joanne E Sordillo; Ken Kleinman; Carlos A Camargo; Augusto A Litonjua; Emily Oken; Joan M Cook-Mills Journal: J Allergy Clin Immunol Date: 2020-04-25 Impact factor: 14.290